Homology Medicines, Inc. |
Director |
Stock Option (Right to Buy) |
12.8K |
$171K |
$13.42 |
Mar 25, 2024 |
Direct |
Precipio, Inc. |
Director |
Common Stock |
10.1K |
$67.5K |
$6.70 |
Apr 15, 2024 |
Direct |
Homology Medicines, Inc. |
Director |
Common Stock |
5.43K |
$3.1K |
$0.57 |
Mar 25, 2024 |
By the Kathleen LaPorte Revocable Trust |
CERO THERAPEUTICS HOLDINGS, INC. |
Director |
Series A Convertible Preferred Stock |
0 |
$0 |
$1,000.00 |
Sep 25, 2024 |
Direct |
CERO THERAPEUTICS HOLDINGS, INC. |
Director |
Common Stock |
966K |
|
|
Sep 25, 2024 |
By the Kathleen LaPorte Revocable Trust |
CERO THERAPEUTICS HOLDINGS, INC. |
Director |
Stock Option (Right to Buy) |
113K |
|
|
Mar 25, 2024 |
Direct |
89bio, Inc. |
Director |
Stock Option (Right to Buy) |
45.2K |
|
|
Feb 1, 2024 |
Direct |
Bolt Biotherapeutics, Inc. |
Director |
Stock Option (Right to Buy) |
22K |
|
|
Jun 12, 2024 |
Direct |
CERO THERAPEUTICS HOLDINGS, INC. |
Director |
Common Stock |
5.83K |
|
|
Sep 25, 2024 |
Direct |
Precipio, Inc. |
Director |
Stock Option (Right to Buy) |
2K |
|
|
Aug 31, 2024 |
Direct |
89bio, Inc. |
Director |
Common Stock |
0 |
|
$11.53 |
Jul 17, 2023 |
Direct |